Corinne Le Goff

CIK 1840912 · Chief Commercial Officer · last filed 2026-04-16

Corinne Le Goff is a Chief Commercial Officer who has filed 16 SEC Form 4 insider transactions across 5 companies since 2021. The most recent filing, for VTRS, was dated Apr 16, 2026. Across all open-market trades the lifetime net is −$72.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.79M

Companies

5

Total Filings

16

Lifetime Open-Market Net

-$72.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VTRS Chief Commercial Officer 108,752 $16.48 $1.79M -$72.0K 8 2026-04-16
Longboard Pharmaceuticals, Inc. (LBPH) Delisted Director $59.98 $0 4 2024-12-02
IMNN President and CEO $2.02 $0 1 2023-03-21
Imunon, Inc. (CLSN) Delisted President and CEO 53,000 $1.96 $103.9K $0 1 2022-07-20
MRNA Chief Commercial Officer $49.91 $0 1 2021-02-02

Recent Filings

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-04-16 VTRS Mixed +23,921 -$264.3K EDGAR
2026-03-10 VTRS Mixed +25,797 -$291.1K EDGAR
2026-03-05 VTRS Mixed +22,118 -$259.7K EDGAR
2025-09-12 VTRS Sell (S) −7,032 -$72.0K EDGAR
2025-04-16 VTRS Mixed +21,234 -$148.7K EDGAR
2025-03-10 VTRS Grant (A) $0 EDGAR
2025-03-05 VTRS Mixed +21,097 -$157.4K EDGAR
2024-12-02 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Disp (D) $0 EDGAR
2024-05-24 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Grant (A) $0 EDGAR
2024-04-19 VTRS Grant (A) $0 EDGAR
Showing 110 of 16
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.